20/20 GeneSystems and its subsidiaries are currently working on the development of 5 products that fall under the In Vitro Diagnostics, Healthcare IT markets. GlobalData’s report 20/20 GeneSystems Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are in the late stage of development.
The main research and development focus of 20/20 GeneSystems is on cancer and infectious diseases.
20/20 GeneSystems: Top therapeutic area(s) by pipeline products
For a complete picture of the developmental pipeline for 20/20 GeneSystems medical devices, buy the report here.